Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act: Guidance for Industry and Food and Drug Administration Staff
Information
Type
Guidance
Regulated products
Biologics, Medical Devices
Topics
Postmarket
Published
November 17, 2023
Last updated
November 16, 2023
Description
Guidance document on notifying FDA of permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)